Pfizer is to start producing supplies of its Covid-19 vaccine from its Grange Castle plant in Dublin as part of a new $40 million investment locally, the company confirmed on Wednesday. Building and securing regulatory approval for vaccine plants is a process that normally takes around two years, but the company said the urgent focus on Covid-19 vaccine supplies means it expects to be ready to go live around the end of this year. We are immensely proud to be able to play a part in manufacturing Pfizer’s Covid-19 vaccine,” said Dr Paul Duffy, vice-president of global supply. Pfizer has been significantly increasing commitments on vaccine supply since first securing approval for the vaccine in mid-December. That has involved upgrading existing plants – including Puurs in Belgium, which is Pfizer’s only European plant producing Covid-19 vaccine currently – as well as signing a third-party supply deal with vaccine giant Sanofi to boost supplies.

Source: The Irish Times May 19, 2021 11:03 UTC